Article
Advancements in the Understanding of Paclitaxel Metabolism in Tissue Culture
29 Jul 2007
Abstract excerpt
Paclitaxel is a potent chemotherapeutic agent approved in the treatment of a variety of cancers, and under evaluation for the treatment of Alzheimer's and heart disease. Originally isolated from Taxus brevifolia, this highly substituted ring diterpenoid belongs to a family of plant secondary metabolites known as taxoids. Paclitaxel is currently supplied through both a semi-synthetic process and plant cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
